Stock A185750 CHONG KUN DANG PHARMACEUTICAL CORP.
Add to a list
To use this feature you must be a member
Log inSign up

Calendar Chong Kun Dang Pharmaceutical Corp.

Equities

A185750

KR7185750007

End-of-day quote Korea S.E.
Other stock markets
 23:00:00 06/05/2024 BST 		5-day change 1st Jan Change
103,100 KRW +1.18% Intraday chart for Chong Kun Dang Pharmaceutical Corp. -1.15% -21.24%
04-25 Tranche Update on Chong Kun Dang Pharmaceutical Corp.'s Equity Buyback Plan announced on January 23, 2024. CI
01-23 Chong Kun Dang Pharmaceutical Corp. announces an Equity Buyback for KRW 15,000 million worth of its shares. CI

Chart calendar Chong Kun Dang Pharmaceutical Corp.

76fcbc6e40f3c.7HaevIgkFRsfoTsjgN09qw0ao4WMVErikU6jIYTg3jw.hSem1vprX1BmkHxp1JwN6XRZwcjFYHOr5jiUS8qttVaOAvX-3Ut6dWbUcg~bdf61e7d37502e476fd43c6227467905

Upcoming events on Chong Kun Dang Pharmaceutical Corp.

12/05/2024 Q1 2024 Earnings Release (Projected)
12/08/2024 Q2 2024 Earnings Release (Projected)
06/04/2025 Q4 2024 Earnings Release (Projected)
18/05/2025 Q1 2025 Earnings Release (Projected)

Past events on Chong Kun Dang Pharmaceutical Corp.

19/03/2024 Q4 2023 Earnings Release
14/05/2023 Q1 2023 Earnings Release
13/03/2023 Q4 2022 Earnings Release
15/08/2022 Interim 2022 Earnings Release
15/05/2022 Q1 2022 Earnings Release
16/08/2021 Interim 2021 Earnings Release
16/05/2021 Q1 2021 Earnings Release
07/02/2021 FY 2020 Earnings Release
29/03/2020 FY 2019 Earnings Release
13/11/2019 Q3 2019 Earnings Release
14/05/2019 Q1 2019 Earnings Release
25/07/2018 Interim 2018 Earnings Release
23/04/2017 Q1 2017 Earnings Release

Past dividends on Chong Kun Dang Pharmaceutical Corp.

26/12/2023 Annual 1100 KRW
27/12/2022 Annual 1000 KRW
28/12/2021 Annual 1000 KRW
28/12/2020 Annual 1000 KRW
26/12/2019 Annual 900 KRW
26/12/2018 Annual 900 KRW
26/12/2017 Annual 900 KRW
27/12/2016 Annual 900 KRW
28/12/2015 Annual 600 KRW
28/12/2014 Annual 800 KRW

Annual results

Fiscal PeriodDecember 2019 2020 2021 2022 2023 2024
Net sales
Billions KRW		Released
Forecast
Spread 		1 079
1 070
0.85%		1 301
1 310
-0.72%		1 334
1 337
-0.24%		1 472
1 463
0.61%
1 633


1 541

EBITDA
Billions KRW		Released
Forecast
Spread 		94,8
95,2
-0.5%		145
161
-9.83%		119
137
-12.77%		138
141
-2.37%
260


149

EBIT
Billions KRW		Released
Forecast
Spread 		77,0
74,5
3.42%		127
139
-8.61%		94,1
113
-16.67%		107
111
-3.93%
226


115

Earnings before Tax (EBT)
Billions KRW		Released
Forecast
Spread 		72,7
70,7
2.9%		120
134
-10.43%		77,4
95,2
-18.7%		101
108
-6.21%
229


118

Net income
Billions KRW		Released
Forecast
Spread 		53,9
50,3
7.04%		88,7
100
-11.61%		39,4
53,4
-26.14%		82,9
85,2
-2.63%
201


96,2

EPS
KRW		Released
Forecast
Spread 		4 300
3 800
13.17%		7 082
7 579
-6.56%		3 168
4 098
-22.68%		6 771
6 443
5.1%
15 391


7 156

Announcement Date31/01/2008/02/2110/02/2203/02/23--

Quarterly results

Fiscal PeriodDecember 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales
Billions KRW		Released
Forecast
Spread 		355
357
-0.58%		338
335
0.95%		365
352
3.73%		381
371
2.6%		389
379
2.49%		360
357
0.88%		392
378
3.63%		396
397
-0.26%
504

353
355
-0.47%
388


397


388


391

EBITDA
Billions KRW		Released
Forecast
Spread
























121


33,8


42,8


44,0


28,5


40,1

EBIT
Billions KRW		Released
Forecast
Spread 		0,99
20,9
-95.28%		24,3
22,7
7.41%		28,1
26,1
7.75%		39,7
35,8
10.78%		15,0
18,2
-17.31%		30,1
29,0
3.66%		43,4
34,0
27.72%		53,1
48,1
10.34%
116

26,8
25,4
5.26%
32,4


34,3


21,8


31,0

Earnings before Tax (EBT)
Billions KRW		Released
Forecast
Spread 		0,35
18,6
-98.1%		23,6
17,0
38.88%		26,0
20,8
25.37%		37,7
35,9
4.98%		13,6
21,6
-37.11%		30,3
28,0
8.24%		43,3
33,3
29.89%		52,6
45,9
14.65%
115

31,8
25,3
25.51%
29,3


33,1


21,2


28,0

Net income
Billions KRW		Released
Forecast
Spread 		-0,91
6,35
-114.35%		17,2
15,8
8.78%		24,5
17,2
42.18%		29,2
24,8
17.94%		12,1
12,7
-4.6%		34,9
22,0
58.58%		41,8
25,9
61.67%		43,5
39,3
10.86%
93,4

25,1
21,0
19.37%
30,0


31,0


11,0


22,0

Announcement Date10/02/2229/04/2229/07/2228/10/2203/02/2315/05/2328/07/2327/10/23-26/04/24----

Upcoming sector events for Chong Kun Dang Pharmaceutical Corp.

08/05/2024 ZERIA PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release
08/05/2024 ONO PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release
09/05/2024 CIPLA LIMITED: Q4 2024 Earnings Release
09/05/2024 CELLTRION PHARM, INC.: Q1 2024 Earnings Release (Projected)
12/05/2024 DAEWOONG CO., LTD.: Q1 2024 Earnings Release (Projected)
12/05/2024 SAM CHUN DANG PHARM. CO., LTD: Q1 2024 Earnings Release (Projected)
12/05/2024 CAREGEN CO., LTD.: Q1 2024 Earnings Release (Projected)
12/05/2024 CHONG KUN DANG PHARMACEUTICAL CORP.: Q1 2024 Earnings Release (Projected)
12/05/2024 SHINPOONG PHARMACEUTICAL CO.,LTD: Q1 2024 Earnings Release (Projected)
12/05/2024 DAEWOONG PHARMACEUTICAL CO., LTD: Q1 2024 Earnings Release (Projected)
More events

Past sector events for Chong Kun Dang Pharmaceutical Corp.

Today SANOFI INDIA LIMITED: Q1 2024 Earnings Release (Projected)
06/05/2024 SANDOZ GROUP AG: Q1 2024 Sales and Revenue Release
02/05/2024 HANMI SCIENCE CO., LTD.: Q1 2024 Earnings Release
02/05/2024 15:34 PROCTER & GAMBLE HEALTH LIMITED: Q3 2024 Earnings Release
02/05/2024 12:09 AJANTA PHARMA LIMITED: Q4 2024 Earnings Release
29/04/2024 SINOTHERAPEUTICS INC.: Q4 2023 Earnings Release
29/04/2024 KUNMING LONGJIN PHARMACEUTICAL CO., LTD.: Q4 2023 Earnings Release
29/04/2024 OTSUKA HOLDINGS CO., LTD.: Q1 2024 Earnings Release
29/04/2024 YIFAN PHARMACEUTICAL CO., LTD.: Q1 2024 Earnings Release
29/04/2024 BORYUNG CORPORATION: Q1 2024 Earnings Release

Net sales - Quarter - Rate of surprise

Net sales - Annual - Rate of surprise

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. A185750 Stock
  4. Calendar Chong Kun Dang Pharmaceutical Corp.